Carbamic acid, (1-(((2-hydroxy-2-(10-(1-methylethyl)-9,12-dioxo-2,5-dioxa-8,11,14-triazabicyclo(1431)eicosa-1(20),16,18-trien-13-yl)-1-(phenylmethyl)ethyl)amino)carbonyl)-2-methylpropyl)-, phenylmethyl ester, (10S-(10R*,13S*(1R*(R*),2S*)))
Modify Date: 2026-03-27 13:55:21
Carbamic acid, (1-(((2-hydroxy-2-(10-(1-methylethyl)-9,12-dioxo-2,5-dioxa-8,11,14-triazabicyclo(1431)eicosa-1(20),16,18-trien-13-yl)-1-(phenylmethyl)ethyl)amino)carbonyl)-2-methylpropyl)-, phenylmethyl ester, (10S-(10R*,13S*(1R*(R*),2S*))) structure
|
Common Name | Carbamic acid, (1-(((2-hydroxy-2-(10-(1-methylethyl)-9,12-dioxo-2,5-dioxa-8,11,14-triazabicyclo(1431)eicosa-1(20),16,18-trien-13-yl)-1-(phenylmethyl)ethyl)amino)carbonyl)-2-methylpropyl)-, phenylmethyl ester, (10S-(10R*,13S*(1R*(R*),2S*))) | ||
|---|---|---|---|---|
| CAS Number | 180968-23-4 | Molecular Weight | 731.9 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C40H53N5O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | Carbamic acid, (1-(((2-hydroxy-2-(10-(1-methylethyl)-9,12-dioxo-2,5-dioxa-8,11,14-triazabicyclo(1431)eicosa-1(20),16,18-trien-13-yl)-1-(phenylmethyl)ethyl)amino)carbonyl)-2-methylpropyl)-, phenylmethyl ester, (10S-(10R*,13S*(1R*(R*),2S*))) |
|---|
| Molecular Formula | C40H53N5O8 |
|---|---|
| Molecular Weight | 731.9 |
| InChIKey | QCOTVEZNURNOOS-YQYWCZHNSA-N |
| SMILES | CC(C)[C@H]1C(=O)NCCOCCOC2=CC=CC(=C2)CN[C@@H](C(=O)N1)[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)NC(=O)OCC4=CC=CC=C4)O |
|
Name: Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected M...
Source: ChEMBL
Target: Human immunodeficiency virus 1
External Id: CHEMBL711617
|
|
Name: Inhibition of HIV-1 proteinase was assayed in infected MT-4 cells
Source: ChEMBL
Target: Pol polyprotein
External Id: CHEMBL763373
|
|
Name: Aqueous solubility in phosphate buffer of pH 7.4
Source: ChEMBL
Target: N/A
External Id: CHEMBL632718
|
Total 5, Current Page 1 of 1
1